Synthesis of hydrophilic conjugated porphyrin dimers for one-photon and two-photon photodynamic therapy at NIR wavelengths

被引:123
作者
Balaz, Milan [1 ]
Collins, Hazel A. [1 ]
Dahlstedt, Emma [1 ]
Anderson, Harry L. [1 ]
机构
[1] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England
基金
英国工程与自然科学研究理事会;
关键词
SINGLET OXYGEN GENERATION; OPTICAL-PROPERTIES; PHOTOSENSITIZED PRODUCTION; POTENTIAL AGENTS; HUMAN PROSTATE; IN-VIVO; ABSORPTION; EXCITATION; LIGHT; ENHANCEMENT;
D O I
10.1039/b814789b
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
We report the synthesis of a series of hydrophilic butadiyne-linked conjugated zinc porphyrin dimers (1-7), designed as photodynamic therapy (PDT) agents. These porphyrin dimers exhibit exceptionally high two-photon absorption cross sections (delta(max) approximate to 8,000-17,000 GM) and red-shifted linear absorption spectra (lambda(max) approximate to 700-800 nm) making them ideal candidates for one-photon and two-photon excited photodynamic therapy. Four polar triethyleneglycol substituents are positioned along the sides of each dimer, but, on their own, these TEG chains do not confer sufficient solubility in aqueous physiological media for reproducible delivery into live cells. Charged cationic (methylpyridinium and trimethylammonium) and anionic (sulfonate and carboxylate) substituents have been appended to the meso-positions of porphyrin dimers using three synthetic strategies: 1) Suzuki coupling, 2) Sonogashira coupling, and 3) nucleophilic Senge arylation. Approaches 1 and 3 both allow attachment of aromatic substituents directly to the meso-positions of porphyrins. Approach 2 provides a route to hydrophilic porphyrin dimers with an ethyne link between the porphyrin and the polar aromatic substituent. The palladium-catalysed approaches 1 and 2 allow the synthesis of a broader range of meso-capped porphyrins, as many aryl halides are available. However the synthesis of the intermediate required for these routes necessitates a statistical reaction step, which decreases the overall yield. On the other hand, Senge-arylation provides highly regioselective nucleophilic aromatic substitution, and offers higher overall yield than the other routes. All these charged dimers exhibit good solubility in polar solvents (e. g. methanol) and aqueous solvent mixtures (aqueous DMSO or DMF).
引用
收藏
页码:874 / 888
页数:15
相关论文
共 83 条
[71]   5,10,15,20-tetrakis(N-methyl-4-pyridyl)-21H,23H-porphine (TMPyP) as a sensitizer for singlet oxygen imaging in cells:: Characterizing the irradiation-dependent behavior of TMPyP in a single cell [J].
Snyder, JW ;
Lambert, JDC ;
Ogilby, PR .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2006, 82 (01) :177-184
[72]   Subcellular, time-resolved studies of singlet oxygen in single cells [J].
Snyder, JW ;
Skovsen, E ;
Lambert, JDC ;
Ogilby, PR .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (42) :14558-14559
[73]   One-step synthesis of dipyrromethanes in water [J].
Sobral, AJFN ;
Rebanda, NGCL ;
da Silva, M ;
Lampreia, SH ;
Silva, MR ;
Beja, AM ;
Paixao, JA ;
Gonsalves, AMDR .
TETRAHEDRON LETTERS, 2003, 44 (20) :3971-3973
[74]   Water-soluble 99mTc-labeled dendritic novel porphyrins tumor imaging and diagnosis [J].
Subbarayan, M ;
Shetty, SJ ;
Srivastava, TS ;
Noronha, OPD ;
Samuel, AM ;
Mukhtar, H .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 281 (01) :32-36
[75]   Degenerate four-wave mixing studies of butadiyne-linked conjugated porphyrin oligomers [J].
Thorne, JRG ;
Kuebler, SM ;
Denning, RG ;
Blake, IM ;
Taylor, PN ;
Anderson, HL .
CHEMICAL PHYSICS, 1999, 248 (2-3) :181-193
[76]   Vascular targeted photodynamic therapy with palladium-bacteriopheophorbide photosensitizer for recurrent prostate cancer following definitive radiation therapy: Assessment of safety and treatment response [J].
Trachtenberg, J. ;
Bogaards, A. ;
Weersink, R. A. ;
Haider, M. A. ;
Evans, A. ;
McCluskey, S. A. ;
Scherz, A. ;
Gertner, M. R. ;
Yue, C. ;
Appu, S. ;
Aprikian, A. ;
Savard, J. ;
Wilson, B. C. ;
Elhilali, M. .
JOURNAL OF UROLOGY, 2007, 178 (05) :1974-1979
[77]   Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer [J].
Verigos, K ;
Stripp, DCH ;
Mick, R ;
Zhu, TC ;
Whittington, R ;
Smith, D ;
Dimofte, A ;
Finlay, J ;
Busch, TM ;
Tochner, ZA ;
Malkowicz, SB ;
Glatstein, E ;
Hahn, SM .
JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2006, 25 (1-2) :373-387
[78]   Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: Clinical experience and practicalities [J].
Weersink, RA ;
Bogaards, A ;
Gertner, M ;
Davidson, SRH ;
Zhang, K ;
Netchev, G ;
Trachtenberg, J ;
Wilson, BC .
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY, 2005, 79 (03) :211-222
[79]   Assessment of cutaneous photosensitivity of TOOKAD (WST09) in preclinical animal models and in patients [J].
Weersink, RA ;
Forbes, J ;
Bisland, S ;
Trachtenberg, J ;
Elhilali, M ;
Brún, PH ;
Wilson, BC .
PHOTOCHEMISTRY AND PHOTOBIOLOGY, 2005, 81 (01) :106-113
[80]   A clearer vision for in vivo imaging [J].
Weissleder, R .
NATURE BIOTECHNOLOGY, 2001, 19 (04) :316-317